12 articles tagged with #computational-biology. AI-curated summaries with sentiment analysis and key takeaways from 50+ sources.
AlphaFold has significantly accelerated scientific research and biological discovery over the past five years. The AI system has enabled breakthroughs in protein structure prediction, fueling innovation across the global scientific community.
NVIDIA has made Evo 2, the largest publicly available AI foundation model for genomic data, accessible through its BioNeMo platform. The model was developed in collaboration with Arc Institute and can understand genetic code across all domains of life, built on NVIDIA's DGX Cloud platform.
Researchers introduce MAT-Cell, a neuro-symbolic AI framework that combines large language models with biological constraints to improve single-cell annotation accuracy. The system uses multi-agent reasoning and verification processes to overcome limitations in both supervised learning and LLM-based approaches, demonstrating superior performance on cross-species benchmarks.
MaxToki is a new AI foundation model that can predict cellular aging patterns and trajectories, addressing a key limitation in existing biological models that only analyze cells as static snapshots. The technology represents a significant advancement in computational biology by incorporating temporal dynamics into cellular analysis.
Researchers developed a pharmacology knowledge graph for drug repurposing and found that removing chemical structure representations improved performance while dramatically reducing computational requirements. The study showed that drug behavior can be accurately predicted using only target protein information and network topology, with larger datasets proving more valuable than complex models.
Researchers propose a new iterative distillation framework for fine-tuning diffusion models in biomolecular design that optimizes for specific reward functions. The method addresses stability and efficiency issues in existing reinforcement learning approaches by using off-policy data collection and KL divergence minimization for improved training stability.
Researchers conducted the first empirical study analyzing how natural scientists reuse pre-trained deep learning models across 17,511 peer-reviewed papers from 2000-2025. The study found that biochemistry and molecular biology lead in model reuse, with adaptation being the most common reuse pattern, primarily impacting the testing phase of scientific research.
Researchers developed a comprehensive benchmarking system to evaluate AI agent performance in single-cell omics analysis, testing 50 real-world tasks across multiple frameworks. The study found that Grok3-beta achieved state-of-the-art performance, while multi-agent frameworks significantly outperformed single-agent approaches through specialized role division.
Researchers developed MEDNA-DFM, a dual-view deep learning model that predicts DNA methylation patterns while providing biological explanations. The model achieves high accuracy across species and includes explainable AI features that reveal conserved genetic motifs and cooperative sequence-structure relationships.
Professor James Collins discusses how collaboration has been central to his research combining computational predictions with experimental platforms to accelerate therapeutic drug discovery and design using AI technologies.
MIT Assistant Professor Yunha Hwang uses computational methods to study microbial genomes and understand biological language. Her appointment demonstrates MIT's focus on combining genetics research with artificial intelligence applications.
Intel has developed optimizations to accelerate the ProtST protein language model on their Gaudi 2 AI accelerator hardware. This advancement demonstrates Intel's commitment to supporting specialized AI workloads in computational biology and scientific research applications.
